Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HAPH Registry: Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.

NCT06489730 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT06489730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06489730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HAPH Registry: Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2024
Completion date
December 31, 2024
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

high altitude pulmonary hypertension, sleep apnea